Founder and chief executive of United Therapeutics
Appears in 2 stories
Led the company's organ-manufacturing expansion into New Hampshire
A former Anheuser-Busch brewery in Merrimack, New Hampshire, is becoming an organ-manufacturing site. United Therapeutics, a biotech company that builds 3D-printed organ scaffolds and gene-edited pig organs, paid $47.5 million for the nearly 300-acre property that Anheuser-Busch shut down in December.
Updated 1 hour ago
Leading the company's push toward a manufactured organ supply
More than 8 in 10 donor lungs recovered from deceased donors never reach a patient. On June 29, 2026, the FDA approved a device built to change that math. United Therapeutics won premarket approval for LungFX, a system that keeps donor lungs warm, ventilated, and pumped with fluid outside the body so transplant teams can re-examine organs they had already rejected.
Updated Jun 29
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
